Go Symbol Lookup
Loading...

Midday Movers: GMCR, LULU & More

 Text Size  
Published: Monday, 3 Dec 2012 | 12:16 PM ET


Take a look at some of Monday's midday movers:

Green Mountain Coffee continued to gain after Lazard Capital hiked its price target on the specialty coffee maker's stock to $56 from $42 a share, saying it is becoming more confident in the company's competitiveness.

Lululemon Athletica moved higher after Cannacord began coverage of the company with a "buy" rating and a price target of $91 a share.

Dean Foods rose after it sold its Morningstar dairy division to Canada's dairy products maker Saputo for $1.45 billion.

VeriSign gained ground after Barron's said its new contract was better than it was perceived since it guaranteed six years of revenue. The stock dropped sharply on Friday after the registry contract was announced.

Netflix lost ground after a cautious Wall Street Journal article on the company's attempt to line up original programming.

Merck moved higher after the company announced it is beginning a new trial to test its experimental Alzheimer's drug.

Ford gained ground after reporting better-than-expected November vehicle sales. General Motors dipped after reporting weaker-than-expected November vehicle sales while Toyota also fell after reporting sales in line with forecasts.

Supervalu moved higher after private equity firm Cerberus indicated its willingness to pursue multiple options, including a deal to buy the troubled grocer, according to Wall Street Journal.

Health Management Associates lost ground after a 60 Minutes segment on Sunday alleged that doctors were being pressured to admit patients from the emergency room to fill hospital beds.

Myriad Genetics fell after Mizuho downgraded the stock "neutral."

Computer Sciences gained ground after selling its credit services unit to Equifax for $1 billion in cash.

International Game Technology moved higher after Deutsche Bank upgraded the slot-machine maker to "buy" and increased its price target to $19 from $16 a share.

Boston Scientific rose after JP Morgan upgraded the medical device maker to "market outperform" and set a $9 price target, citing its pipeline of products.

MGIC Investment Corp rose after the company said it won approval from Freddie Mac to sell coverage out of a new subsidiary.

QLogic and Emulex both fell after Goldman Sachs downgraded the stocks to "sell" from "neutral," citing cyclical risk from the server market.

SunCoke Energy plummeted after the company deferred plans for an energy partnership IPO.

(Read More: See CNBC's Market Insider Blog)

—By CNBC's Rich Fisherman.

Questions? Comments? Email us at marketinsider@cnbc.com

 Print
Take a look at some of Monday's midday movers:
  Price   Change %Change
GMCR ---
LLL ---
DF ---
VRSN ---
NFLX ---
MRK ---
F ---
GM ---
7203.T ---
SVU ---
HMA ---
MYGN ---
CSC ---
IGT ---
SUNCOKE NRG ---
QLGC ---
MTG ---
ELX ---
BSX ---
EFX ---

   
Comments

 

More Comments

 
 

Add Comments

 

Your Comments (Up to 1100 characters):

Remaining characters

Your comments have not been posted yet.

Please review your submission to make sure you are comfortable with your entry.

Your Comments:


                
            
            
        

Featured

  • Patti Domm is CNBC Executive Editor, News, responsible for news coverage of the markets and economy.

  • Greenberg is senior stocks commentator for CNBC appearing throughout business day programming and on CNBC.com.

  • A CNBC reporter since 1990, Pisani reports on Wall Street and the stock market from the floor of the New York Stock Exchange. Follow him on Twitter @BobPisani.

  • Epperson covers the global energy, metals and commodities markets from the NY Mercantile Exchange for CNBC and CNBC.com.

  • Santelli joined CNBC Business News as an on-air editor in 1999, reporting live from the floor of the Chicago Board of Trade.

  • Senior Editor at CNBC, commodity trader in a former life.

  • CNBC Markets Producer

  • Senior Producer at CNBC's Breaking News Desk.

  • Website Producer at CNBC